Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Neoplasms 5 Stomach Neoplasms 3 Pain, Postoperative 2 Pain 2 Motor Activity 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Fatigue 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma 1 Psychological Well-Being 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Lymphoma 1 Lymphedema 1 Lymphatic Metastasis 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Incisional Hernia 1 Hernia, Abdominal 1 Heart Failure 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diarrhea 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Doxorubicin 19 Radiotherapy 10 Ifosfamide 10 apatinib 9 anlotinib 8 Cyclophosphamide 8 camrelizumab 7 Vincristine 5 Dactinomycin 5 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Etoposide 3 Docetaxel 3 ribociclib 2 brostallicin 2 Topotecan 2 Thalidomide 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Neoadjuvant Therapy 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Gene Expression Profiling 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × Control Groups × Clear all

NCT04518488 2020-09-21

Prehabilitation Soft-Tissue Sarcoma of Lower Limb

McGill University

Phase NA Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡